| Name | Walgreens #9248 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 2300 Otis Dr, Alameda, California 94501 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (510) 523-7043 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers from the University of Liverpool's Institute of Translational Medicine have been awarded a grant of up to US$ 8.9 million (GBP £5.8m) to lead a multinational research consortium that aims to reduce mother-to-child transmission of HIV.
Grand Challenges Canada today commended the Government of Canada's sustained leadership on maternal, newborn and child health, reaffirmed by The Honourable Minister Paradis, Minister of International Development and Minister for La Francophonie.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ibandronate Sodium Tablets, 150mg.
The IDSA Center for Global Health Policy and the HIV Medicine Association recently released a policy statement responding to the results of the HPTN 052 study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) at NIH, which found that people with HIV who received immediate antiretroviral therapy (ART) were more than 96 percent less likely to sexually transmit the infection to their uninfected partners.
› Verified 5 days ago
| NPI Number | 1326053695 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #09248 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2300 Otis Dr, Alameda, CA 94501 |
| Phone Number | 510-523-7043 |
News Archive
Researchers from the University of Liverpool's Institute of Translational Medicine have been awarded a grant of up to US$ 8.9 million (GBP £5.8m) to lead a multinational research consortium that aims to reduce mother-to-child transmission of HIV.
Grand Challenges Canada today commended the Government of Canada's sustained leadership on maternal, newborn and child health, reaffirmed by The Honourable Minister Paradis, Minister of International Development and Minister for La Francophonie.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ibandronate Sodium Tablets, 150mg.
The IDSA Center for Global Health Policy and the HIV Medicine Association recently released a policy statement responding to the results of the HPTN 052 study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) at NIH, which found that people with HIV who received immediate antiretroviral therapy (ART) were more than 96 percent less likely to sexually transmit the infection to their uninfected partners.
› Verified 5 days ago
News Archive
Researchers from the University of Liverpool's Institute of Translational Medicine have been awarded a grant of up to US$ 8.9 million (GBP £5.8m) to lead a multinational research consortium that aims to reduce mother-to-child transmission of HIV.
Grand Challenges Canada today commended the Government of Canada's sustained leadership on maternal, newborn and child health, reaffirmed by The Honourable Minister Paradis, Minister of International Development and Minister for La Francophonie.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Ibandronate Sodium Tablets, 150mg.
The IDSA Center for Global Health Policy and the HIV Medicine Association recently released a policy statement responding to the results of the HPTN 052 study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) at NIH, which found that people with HIV who received immediate antiretroviral therapy (ART) were more than 96 percent less likely to sexually transmit the infection to their uninfected partners.
› Verified 5 days ago
Bay Area Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 845 Central Ave, Alameda, California 94501 Phone: (510) 748-9700 | |
Cvs Pharmacy #17657 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2700 5th St, Alameda, California 94501 Phone: (510) 214-0932 | |
Cvs Pharmacy #09128 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2314 Santa Clara Ave, Alameda, California 94501 Phone: (510) 523-4929 | |
Cvs Pharmacy #09250 Type: Medicare Supplier Location: 885 Island Dr, Alameda, California 94502 Phone: (510) 865-2155 | |
Cvs Pharmacy #09255 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 931 Marina Village Pkwy, Alameda, California 94501 Phone: (510) 523-3504 |